FFTY

Innovator IBD 50 ETF

$34.35
+0.00%
Market closed. Last update: 10:55 PM ET

📎 Investment Objective

The Innovator IBD 50 ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the IBD 50 Index.

Overview

ETF tracking Innovator IBD 50 ETF

Category Other
Issuer Other
Inception Date 2015-04-09
Market Cap $80.7M
Average Volume N/A
Dividend Yield 0.75%
52-Week Range $23.76 - $41.09
VWAP $34.19

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The Innovator IBD 50 ETF seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the IBD 50 Index.

🎯 Investment Strategy

The fund uses a passive management (or index-tracking) strategy designed to track the performance of the IBD 50 Index, which is comprised of 50 growth stocks selected based on a proprietary methodology developed by Investor's Business Daily.

✨ Key Features

  • Tracks the IBD 50 Index, a growth-oriented stock index
  • Passively managed to replicate the index's performance
  • Relatively low expense ratio of 0.00%
  • Suitable for investors seeking exposure to a portfolio of growth stocks

⚠️ Primary Risks

  • Market risk: The value of the fund's shares will fluctuate with changes in the stock market
  • Concentration risk: The fund is concentrated in a relatively small number of stocks, which can increase volatility
  • Tracking error risk: The fund may not perfectly track the performance of the underlying index
  • Liquidity risk: The fund may have difficulty trading certain securities at an advantageous time and price

👤 Best For

The Innovator IBD 50 ETF may be suitable for investors seeking exposure to a portfolio of growth-oriented stocks, as part of a diversified investment strategy. Investors should have a medium to long-term investment horizon and be comfortable with the risks associated with investing in a concentrated portfolio of equities.